Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | |
---|---|---|---|---|
Gynocular | ||||
10 vs <10 | 5.6% (0.7% to 18.7%) | 97.4% (94.0% to 99.1%) | 84.5% (79.1% to 89.1%) | 28.6% (3.7% to 71.0%) |
≥9 vs <9 | 22.2% (10.1% to 39.2%) | 93.7% (89.3% to 96.7%) | 86.5% (81.0% to 90.8%) | 40.0% (19.1% to 63.9%) |
≥8 vs <8 | 36.1% (20.8% to 53.8%) | 88.0% (82.5% to 92.2%) | 88.0% (82.5% to 92.2%) | 36.1% (20.8% to 53.8%) |
≥7 vs <7 | 52.8% (35.5% to 69.6%) | 74.9% (68.1% to 80.9%) | 89.4% (83.5% to 93.7%) | 28.4% (18.0% to 40.7%) |
≥6 vs <6 | 61.1% (43.5% to 76.9%) | 52.9% (45.5% to 60.1%) | 87.8% (80.4% to 93.2%) | 19.6% (12.7% to 28.2%) |
≥5 vs 4 | 83.3% (67.2% to 93.6%) | 22.0% (16.3% to 28.5%) | 87.5% (74.8% to 95.3%) | 16.8% (11.6% to 23.1%) |
Colposcope | ||||
10 vs <10 | 5.6% (0.7% to 18.7%) | 97.4% (94.0% to 99.1%) | 84.5% (79.1% to 89.1%) | 28.6% (3.7% to 71.0%) |
≥9 vs <9 | 19.4% (8.2% to 36.0%) | 93.2% (88.6% to 96.3%) | 86.0% (80.5% to 90.4%) | 35.0% (15.4% to 59.2%) |
≥8 vs <8 | 36.1% (20.8% to 53.8%) | 88.0% (82.5% to 92.2%) | 88.0% (82.5% to 92.2%) | 36.1% (20.8% to 53.8%) |
≥7 vs <7 | 52.8% (35.5% to 69.6%) | 75.4% (68.7% to 81.3%) | 89.4% (83.6% to 93.7%) | 28.8% (18.3% to 41.3%) |
≥6 vs <6 | 61.1% (43.5% to 76.9%) | 53.4% (46.1% to 60.6%) | 87.9% (80.6% to 93.2%) | 19.8% (12.9% to 28.5%) |
≥5 vs 4 | 83.3% (67.2% to 93.6%) | 22.5% (16.8% to 29.1%) | 87.8% (75.2% to 95.4%) | 16.9% (11.7% to 23.2%) |
PPV, positive predictive value; NPV, negative predictive value.